August of Action Continues: Key Meetings with Sen. John Thune, Chairman Jason Smith, and Rep. Randy Feenstra

Published in Government Relations on September 03, 2024

As the August recess draws to a close, there are still ample opportunities to engage with your legislators before the upcoming election. Throughout October and leading up to the election, legislators will be back in their home states, providing a perfect window to connect with them before the end of the year. 

Below is a recap of the key meetings held over the past weeks. The consistent message from these discussions has been the urgent need for H.R.5555/S.1294 to find a legislative vehicle for passage before the year’s end. 

Ways and Means

August 19: Pat Naeger and Rose Schafhauser of MAMES organized an event with Chairman of the Ways and Means Committee, Jason Smith (MO-8). Mike “Ike” Isaacson from VGM attended as well. The event saw a significant turnout of DME suppliers and other DMEPOS industry representatives. Special thanks to Patrick Naeger for organizing this crucial event and establishing contact with a key legislator for rural communities. 

Govt relations

August 22: MAMES members, DME suppliers from South Dakota, and industry leaders from VGM (John Gallagher and Emily Harken), AAHomecare (Jay Witter), and Pride (Seth Johnson) met with Sen. John Thune in Sioux Falls, SD. Sen. Thune, a long-time supporter of the DMEPOS industry, heard attendees emphasize the critical importance of passing DME legislation (S.1294) in an end-of-year package. 

Feenstra

August 28: Choice Medical of Ames, IA, hosted a meeting with Rep. Randy Feenstra (IA-4). John Gallagher and Emily Harken from VGM also attended this event. This meeting provided an excellent opportunity to update Rep. Feenstra on the discussions from previous events. As a member of the House Ways and Means Committee, Rep. Feenstra has strong working relationships with both Republicans and Democrats. 

These meetings are timely, reinforcing the importance of passing DMEPOS legislation and improving reimbursement rates. Smith, Thune, and Feenstra have all committed to collaborating with each other and other key legislators to maintain momentum for the passage of H.R.5555/S.1294 in an end-of-year package. 

A heartfelt thank you to MAMES, all the DME suppliers, and industry representatives who attended these events. We remain hopeful that these summer meetings will lead to the successful passage of DME legislation by the end of the year. 


TAGS

  1. advocacy
  2. legislation
  3. regulatory
  4. vgm government

From Our Experts

Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart. Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program thumbnail Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program Many of you have already contacted your legislators in support of key DME legislation, including the DMEPOS Relief Act, the Choices for Increased Mobility Act, and the Supplemental Oxygen Access Reform (SOAR) Act. We now have another important issue to bring to your attention. CMS Revises Nebulizer Policy and ABN Form thumbnail CMS Revises Nebulizer Policy and ABN Form CMS has issued an update regarding revisions to the CMS Nebulizer Policy Article and guidance on the Advanced Beneficiary Notice of Noncoverage (ABN) Form. For dates of service on or after Feb. 1, 2026, suppliers must include the KX, GA, or GZ modifier to claims for the following nebulizer items: CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 thumbnail CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 Earlier this week, Congress extended Medicare telehealth flexibilities through Dec, 31, 2027, as part of the newly signed federal funding bill. In response, CMS has released updated Telehealth Frequently Asked Questions (FAQ) to provide clarity on what the extension means for both patients and providers.